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Abstract The syndromic primary immunodeficiencies are
disorders in which not only the immune system but also
other organ systems are affected. Other features most
commonly involve the ectodermal, skeletal, nervous, and
gastrointestinal systems. Key in identifying syndromic
immunodeficiencies is the awareness that increased suscep-
tibility to infections or immune dysregulation in a patient
known to have other symptoms or special features may hint
at an underlying genetic syndrome. Because the extraim-
mune clinical features can be highly variable, it is more
difficult establishing the correct diagnosis. Nevertheless,
correct diagnosis at an early age is important because of
the possible treatment options. Therefore, diagnostic work-
up is best performed in a center with extensive expertise in
this field, having immunologists and clinical geneticists, as
well as adequate support from a specialized laboratory at
hand. This paper provides the general pediatrician with the
main clinical features that are crucial for the recognition of
these syndromes.
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Abbreviations
WAS Wiskott–Aldrich syndrome
CHH Cartilage–hair hypoplasia
NBS Nijmegen breakage syndrome
A-T Ataxia telangiectasia
ICF syndrome Immunodeficiency centromeric instability
and facial dysmorphisms syndrome
HIES Hyper-IgE syndrome
DS Down syndrome
syndromic PID Syndromic primary immunodeficiencies
SCID Severe combined immunodeficiency
BMT Bone marrow transplantation
HSCT Hematopoietic stem cell transplantation
Introduction
The syndromic primary immunodeficiencies (syndromic
PID) are disorders in which not only the immune system
but also other organ systems are affected. In contrast to
other primary immunodeficiencies, more often features
other than the immune-defect are the presenting symptoms.
Nevertheless, patients with syndromic PID may present
with recurrent infections as well. In many malformation
and/or mental retardation syndromes, increased rates of
infections are assumed to result mainly from anatomical
problems, failing physiological mechanisms, and institu-
tionalization. In contrast, syndromic PID have an intrinsic
abnormality of the immune system that increases suscepti-
bility to infections. Within the IUIS classification system,
syndromic PID are mainly found in the category of “other
well defined immunodeficiency syndromes” but are present
in many other categories as well [54]. We advocate using
the name “syndromic PID” because it lays more emphasis
on the extraimmune phenotype, which, in fact, can be
prominent.
Syndromic PID can be caused by single gene disorders,
metabolic aberrations, and chromosomal abnormalities, and
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general, the genetic defects in syndromic PID impact on
important cellular processes thereby affecting multiple cell
lines and organ systems. In DNA repair disorders (ataxia
telangiectasia, Bloom syndrome, and Nijmegen breakage
syndrome), all cells are affected resulting in severe growth
retardation, neurological disease in some, increased suscep-
tibility to malignancy, and predisposition to infections.
Immunodeficiency likely results from aberrant DNA repair
in lymphocytes during the somatic recombination events,
such as V(D)J recombination (the process of antigen
receptor diversification by combining different gene seg-
ments) and class switch recombination (the process of
immunoglobulin isotype switching) that are necessary to
generate the enormous range of specificities of antigen
receptors [79]. In other syndromic PID such as hyper-IgE
syndrome, Wiskott–Aldrich syndrome or hypohidrotic
ectodermal dysplasia with immune-deficiency, signaling
molecules are affected that transmit signals from a variety
of receptors in different cell types thereby resulting in
features in several organ systems.
This paper provides the general pediatrician with the
main clinical features that are crucial for the recognition of
syndromic PID [49]. In addition, a short overview of
current diagnostic and therapeutic options is given. In
Table 1, an overview is provided that helps making a
differential diagnosis starting from several lead symptoms
such as, e.g., facial dysmorphisms, growth failure, and skin
problems. For the general diagnostic approach, readers are
referred to the first paper in this educational series (de Vries
and Driessen).
Ataxia telangiectasia
Ataxia telangiectasia (A-T; OMIM 208900) is an auto-
somal recessive disorder caused by mutations in the
ATM-gene, a protein kinase that is involved in DNA repair
[66]. Clinical features are progressive cerebellar ataxia,
oculocutaneous telangiectasias, immunodeficiency, and
increased susceptibility to malignancies, particularly lym-
phomas and leukemias [70]. Ataxia develops shortly after
learning to walk and begins as truncal ataxia but, within
several years, involves peripheral coordination as well.
Neurological disturbances also include extrapyramidal
symptoms (Fig. 1a-1). From about 10 years on, most
children become wheelchair-bound for the remainder of
their lives. The hallmark feature of A-T “oculocutaneous
telangiectasias” usually appears at about 4 to 6 years of
age (Fig. 1a-2).
Most patients suffer from recurrent respiratory infec-
tions. Systemic bacterial, severe viral, and opportunistic
infections are uncommon in A-T. In patients with
classical A-T, both humoral and cellular immunity are
disturbed with IgA, IgG2, and IgG4 deficiency as most
common manifestations [55]. However, 10% of A-T
patients present with decreased serum IgG and IgA with
normal or raised IgM levels, resulting in more severe
infections, thus showing a phenotype reminiscent of
hyper-IgM syndrome [52]. Antibody responses to tetanus
and diphtheria toxoid show protective levels, but the
majority has a specific polysaccharide antibody deficien-
cy. T cells have been found to be decreased in a
considerable fraction of patients, with a specific reduction
in the numbers of naïve CD4+ cells (CD4+CD45RA+
cells) and naïve CD8+ cells (CD8+CD45RA+ cells). NK
cell numbers are elevated [67].
In recent years, it was recognized that some patients
present with a milder form of A-T, atypical A-T. Although
affected patients had extrapyramidal symptoms (even in
childhood), ataxia was less severe or even absent and
patients were not wheelchair-bound and had normal
immunoglobulins [73, 82]. Whereas classical A-T is
characterized by loss of function, atypical A-T cases
typically have some residual ATM kinase activity left.
Diagnosis of A-T can be suspected from the combination
of clinical features, a slight increase in blood α-fetoprotein
in the majority of patients and from typical cytogenetic
aberrations. Standard karyotyping of peripheral blood
lymphocytes can be difficult because lymphocytes are less
responsive to mitogenic stimuli resulting in few meta-
phases. When successful, a 7;14 translocation can be found
in 5–15% of lymphocytes. More commonly, a radiosensi-
tivity assay of lymphoblasts or fibroblasts is used to
confirm A-T.
In all patients with classical Ataxia teleangiectasia, 
teleangiectasias are absent in the first years of 
life. Ataxia develops shortly after learning to walk.
Nijmegen breakage syndrome
Nijmegen breakage syndrome (NBS; OMIM 251260) is
a rare autosomal recessive disorder first described in
1981 by Weemaes et al. in two brothers with micro-
cephaly, small stature, facial dysmorphisms, and immu-
nodeficiency [83] .N B Si sm o r ec o m m o ni nE a s t e r n
European and Slavic populations due to a relatively high
carrier frequency. In 1998, the gene causing NBS was
discovered, and it was shown that mutations in the NBS1-
g e n er e s u l t e di nl o s so fN B S 1a n dd e f i c i e n tD N Ar e p a i r
[81].
296 Eur J Pediatr (2011) 170:295–308Table 1 Considerations on the differential diagnosis in patients presenting with:
Disease T cells B cells Serum Ig Associated features Molecular defect
MICROCEPHALY
DNA ligase IV
deficiency
↓↓ ↓ Growth retardation, dysmorphisms,
radiation sensitivity
DNA ligase IV
Cernunnos
deficiency
↓↓ ↓ Intrauterine and postnatal growth
retardation, radiation sensitivity
Cernunnos
Nijmegen
breakage
syndrome
↓ N ↓ Often IgA↓
IgG2 ↓
Bird-like face, radiation sensitivity NBS1 (NBN)
Rad 50 deficiency N N Radiation sensitivity RAD50
Bloom syndrome N N reduced Intrauterine and postnatal growth
retardation, sun-sensitive erythema,
short stature
recQ-like
helicase BLM
Hoyeraal–Hreidarsson
syndrome
N ↓ N ↓ variable Cerebellar hypoplasia, intrauterine
growth retardation, pancytopenia
DKC1
GROWTH DEFECT
Dysproportional
Cartilage–hair hypoplasia ↓ N normal or
reduced
Short-limbed dwarfism, sparse hair MRMP
Schwachman-Diamond
syndrome
N N normal Pancytopenia, exocrine pancreatic
insufficiency
SBDS
Proportional
Bloom syndrome N N reduced Intrauterine and postnatal growth
retardation, sun-sensitive erythema,
short stature
recQ-like
helicase BLM
Nijmegen breakage
syndrome
↓ N ↓ Often IgA↓
IgG2 ↓
Bird-like face, radiation sensitivity NBS1 (NBN)
Cernunnos ↓↓ ↓ Intrauterine and postnatal growth
retardation, radiation sensitivity
Cernunnos
FACIAL DYSMORPHISMS
ICF syndrome N ↓ N ↓ Hypogammaglobulinemia Centromeric instability, infections DNMT3B/?
Bird-like face
Nijmegen breakage
syndrome
↓ N ↓ Often IgA↓
IgG2 ↓
Bird-like face, radiation sensitivity NBS1 (NBN)
Cernunnos ↓↓ ↓ Intrauterine and postnatal growth
retardation, radiation sensitivity
Cernunnos
Ligase IV deficiency ↓↓ ↓ Growth retardation, dysmorphisms,
radiation sensitivity
DNA ligase IV
Down syndrome
(e.g. trisomy 21)
N N N-reduced Dysmorphisms Chromosomal
disorder
22q11 Deletion ↓ N N-reduced Conotruncal malformation,
velopharyngeal insufficiency
Chromosomal
disorder
Hyper-IgE syndrome
AD
Th17 ↓ N IgE ↑ Distinctive facial features, fractures,
scoliosis, retained primary dentition
STAT3
Hyper-IgE syndrome
AR
Th17 N-↓ N IgE ↑ Some have distinctive facial features,
susceptibility to viral infections and
mycobacterial infections
DOCK8, TYK2
SKIN DISORDERS
Omenn syndrome restricted N ↓ Decreased,
IgE ↑
Erythroderma, SCID RAG1/2, Artemis,
ADA,
unknown.
Atopic Dermatitis
Wiskott–Aldrich
Syndrome
N ↓ N IgM ↓, IgA↑,
IgE ↑
Microthrombocytopenia WAS
Hyper-IgE syndrome
AD
Th17 ↓ N IgE ↑ Distinctive facial features, fractures,
scoliosis, retained primary dentition
STAT3
Eur J Pediatr (2011) 170:295–308 297Characteristic clinical features include microcephaly,
growth retardation, bird-like facial features, combined
immunodeficiency, and a strong predisposition for lym-
phoid malignancies (Fig. 1b)[ 32, 83]. All patients have
microcephaly and short stature, their body length being
below the 10th centile in all cases. In about 75%,
microcephaly is already present at birth. The facial
appearance is characterized by a receding forehead,
prominent midface with long nose and long philtrum,
receding mandible, upward slanting of palpebral fissures,
epicanthic folds, large ears with dysplastic helices, and
sparse hair. The distinctive facial features may not be
present before the age of 3 years. Commonly clinodactyly
and/or syndactyly may be found. In almost all patients, skin
pigmentary changes can be observed. Although mental
development was normal in 22 out of 55 patients (40%),
about 28 out of 55 patients (50%) had borderline to mild
retardation, while five out of 55 patients (10%) were
moderately mentally retarded [32]. In a minority of cases,
congenital malformations are found. Predisposition to
lymphoid malignancy is strong.
Patients suffer from repeated infections, most frequently
recurrent airway and ENT infections followed by recurrent
urinary tract infections [32]. Commonly, IgG and IgA
deficiency is found and less frequently IgA deficiency is
accompanied by IgG2 and/or IgG4 deficiency, while IgM
deficiency is rare [32]. Often, the percentage of T cells is
decreased, due to low numbers of CD4+ T cells. Especially
naïve CD4+ cells (CD4+CD45RA+ cells) have been shown
to be reduced. The frequency of CD8+ cells usually does not
appear to be affected [32, 46]. NK cells are normally present.
In vitro responses of lymphocytes to mitogenic stimuli such
as phytohemagglutinin (PHA) are decreased in most patients.
Diagnosis can be suspected from standard karyotyping
of peripheral blood lymphocytes, revealing inversions and
translocations involving chromosomes 7 and 14 in 10–50%
of metaphases. Furthermore, radiosensitivity of fibroblasts
or lymphocytes may be increased.
Table 1 (continued)
Disease T cells B cells Serum Ig Associated features Molecular defect
Hyper-IgE syndrome
AR
Th17 N -↓ N IgE ↑ Some have distinctive facial features,
susceptibility to viral infections and
mycobacterial infections
DOCK8, TYK2
STAT5b deficiency ↓ N Normal Growth hormone insensitive dwarfism STAT5b
Comél-Netherton
syndrome
N ↓ IgE↑ IgA↑
antibodies ↓
Congenital ichthyosiform erythroderma,
trichorrhexis invaginata, and an atopic
diathesis
SPINK5
Anhydrotic ectodermal
dysplasia
NEMO N-↑ 60% IgG ↓, sometimes
hyper-IgM
May have distinctive facial features,
conical incisors, hypohydrosis
NEMO
IκBα deficiency NaiveTcells↑ IgM ↑↑ IgG ↓ Conical teeth IκBα
Ca
2+ channel
deficiency
NN - ↑ N-↑ Severe immunodeficiency, muscular
hypotonia, severely impaired T cell
function
STIM-1, ORAI-1
Chronic mucocutaneous
Candidiasis
N N Normal Defect in Th17 cells CARD9, Dectin-1
Hypopigmentation
Chediak Higashi N N Normal Low NK cells, partial albinism,
encephalopathy
LYST
Griscelli Syndrome N N Normal Partial albinism, encephalopathy
in some
RAB27A
Warts
WHIM ↓ Hypogammaglobulinemia CXCR4
ATAXIA
Ataxia telangiectasia ↓ N-↓ Often IgA↓ IgG2 ↓ Ocular telangiectasia, radiation
sensitivity
ATM
Ataxia telangiectasia
like disease
↓ N Radiation sensitivity MRE11
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been found in some other syndromic immunodeficiencies
such as Cernunnos/XLF and Ligase IV deficiency. Patients
with Cernunnos/XLF deficiency (OMIM 611291) have
growth retardation, microcephaly, dysmorphic features,
and urogenital malformations. Their immunodeficiency is
characterized by mild-to-severe B and T cell lymphopenia,
whereas NK cells are unaffected [6]. Patients with Ligase
IV deficiency (OMIM 606593) are characterized by
microcephaly, growth retardation, a bird-like face, pancy-
topenia, and may have a severe combined immunodeficiency
(SCID) phenotype as well [56, 78].
Prenatal onset of growth deficiency and 
microcephaly, and increased susceptibility to 
infections may  point at DNA repair disorders such as 
Nijmegen breakage syndrome and Bloom syndrome.
Bloom syndrome
Bloom syndrome (OMIM 210900) is an autosomal reces-
sive disorder caused by inactivating mutations in the Blm-
gene, a RecQ-helicase involved in DNA repair [19].
Although Bloom syndrome is very rare, it is found more
frequently in Ashkenazi Jewish populations. Patients
present with severe prenatal and postnatal growth retarda-
tion, microcephaly, and sun-sensitive erythematous lesions
(SLE-like butterfly rash) that are mostly found on sun-
exposed regions of the face (Fig. 1c)[ 24]. In infancy,
vomiting and diarrhea are common problems. Importantly,
Bloom syndrome patients have a significantly increased
risk for one or multiple malignancies. The tumor types and
sites involved resemble that in the general population,
although onset is much earlier. In the first two decades of
life, predominantly, leukemia and non-Hodgkin’s lympho-
ma are found. Later in life, epithelial cancers from the colon
and upper respiratory tract occur more frequently.
Immunodeficiency is highly variable and usually not
severe, although most patients experience recurrent airway
Fig. 1 Photographs highlighting several important clinical features
from four classical syndromic PID, which can be diagnosed by
cytogenetic studies. (a-1, a-2) Ataxia telangiectasia: note the conjunc-
tival telangiectasias and the rather expressionless facies; (b) Nijmegen
breakage syndrome: note the microcephaly, the prominent midface
with long nose and long philtrum, receding mandible, large ears, and
sparse hair; (c) Bloom syndrome: note the butterfly rash on the
cheeks; (d) ICF syndrome: note the epicanthic folds, flat broad nasal
bridge with ocular hypertelorism, and low-set ears
Eur J Pediatr (2011) 170:295–308 299and ENT infections. Left untreated, this can result in
bronchiectasis. Immunoglobulin levels (especially IgM)
are decreased in most patients. T, B, and NK cells are
present in normal numbers, but in vitro responses of
lymphocytes to mitogens can be decreased [84].
Diagnosis can be suspected from standard karyotyping
showing quadriradial configurations and increased numbers
of spontaneous chromatid breaks and gaps. A very specific
confirmatory cytogenetic test evaluates the number of sister
chromatid exchanges per metaphase, which is highly
increased in Bloom syndrome patients.
Classic cytogenetic tests such as standard 
karyotyping of mitogen stimulated lymphocytes and 
evaluation of the frequency of sister chromatid 
exchanges can be very helpful in diagnosing Ataxia  
telangiectasia, Nijmegen breakage syndrome, Bloom 
syndrome and ICF syndrome.
ICF syndrome
Immunodeficiency, centromeric instability, and facial dys-
morphisms syndrome (ICF-syndrome; OMIM 242860) is
an autosomal recessive disease characterized by facial
dysmorphisms, immunodeficiency, and branching of chro-
mosomes 1, 9, and 16 after PHA stimulation of lympho-
cytes [42]. In about half of the patients, mutations in the
DNMT3B-gene, a gene involved in DNA methylation, can
be found [29, 30, 88]. Facial dysmorphism, including
epicanthic folds, hypertelorism, flat nasal bridge, and low-
set ears, are very frequent findings (Fig. 1d)[ 29].
Malignancies have been described infrequently [68].
Recurrentairwayand ENTinfectionsarevery common,but
opportunistic infections were described in several patients as
well. Although hypogammaglobulinemia up to agammaglob-
ulinemia have been shown to be present in nearly all patients,
BandTcellnumbersandsubpopulationsaregenerallynormal.
Diagnosis can be confirmed by standard karyotyping of
mitogen-stimulated lymphocytes revealing formation of
multiradiate chromosomes 1, 9, and 16.
Life expectancy is poor, especially in patients with
severe infections in infancy or chronic gastrointestinal
problems and failure to thrive. Allogeneic stem cell
transplantation has been successfully employed although
long-term results are not yet available [23].
Wiskott–Aldrich syndrome
Wiskott–Aldrichsyndrome(WAS;OMIM301000)isarareX-
linked recessive condition that was first recognized in 1937 by
AlfredWiskott, a German pediatrician, who describeda family
with three boys suffering from the “classical triad” micro-
thrombocytopenia, recurrent infections, and atopic eczema
[57]. WAS is caused by mutations in the WAS-gene which is
located on Xp11.22. Although only males present with the
full spectrum of Wiskott–Aldrich syndrome, incidentally,
females with mild microthrombocytopenia have been
r e p o r t e dc a u s e db ys k e w e dX - i n a c t i v a t i o n[ 3, 53]. WAS
includes a spectrum of disorders including classical WAS, X-
linked thrombocytopenia (XLT), intermittent XLT, and X-
linked congenital neutropenia.
During the first years of life, the main health
problem in classical WAS is thrombocytopenia, resulting
in intermittent mucosal bleeding, bloody diarrhea, and
intermittent or chronic petechiae and purpura [74].
Microthrombocytopenia is mostly congenital and life-
threatening bleeding can be precipitated by serious
infections. About 80% of classical WAS patients also
have mild-to-severe eczema (Fig. 2a). In addition, in
classical WAS, infections are often severe with suscepti-
bility to bacterial, viral (VZV and HSV), and even
opportunistic organisms (Pneumocystis jiroveci). At least
40% of those who survive the early complications develop
one or more autoimmune conditions such as autoimmune
hemolytic anemia, vasculitis, neutropenia, arthritis, renal
disease, and inflammatory bowel disease [16, 69, 74].
Importantly, individuals with WAS have a 13% risk of
developing lymphomas especially when autoimmune
disease is present [74]. Although patients with XLT do
have microthrombocytopenia, eczema and immune dys-
f u n c t i o na r em i l di nc o m p a r i s o nt oc l a s s i c a lW A S .
In patients with classical WAS, both humoral and cellular
immunity are disturbed with lymphocyte numbers decreasing
over time, resulting in mild-to-more-severe lymphopenia [57,
76]. IgM is mostly decreased, whereas IgG remains generally
within normal limits. In contrast, IgA and IgE can be
elevated. Furthermore, serological responses to polysaccha-
ride antigens are markedly depressed, indicative of a specific
polysaccharide antibody deficiency.
Although WAS can be readily recognized on the basis of
the clinical triad this constellation is present in only 25% of
patients with classical WAS at diagnosis [74]. As micro-
thrombocytopenia with increased bleeding tendency is the
most common symptom of WAS, WAS should be consid-
ered in each such case. Diagnosis can be confirmed by a
combination of an assay capable of detecting WASP protein
and genetic testing. Differential diagnosis includes Omenn
syndrome and hyper-IgE syndrome, which may also present
300 Eur J Pediatr (2011) 170:295–308with eczema and severe infections but are not accompanied
by microthrombocytopenia.
Microthrombocytopenia is the most distinctive
feature of Wiskott-Aldrich syndrome, whereas the 
classical triad including microthrombocytopenia, 
recurrent infections and atopic eczema is present in  
only one fourth of patients.
Hyper-IgE syndrome
The hyper-IgE syndrome (HIES) was first described in
1966 by Davis and Wedgwood, which named it the “Job
syndrome”, after the biblical figure Job who was covered
with sore boils [13]. The classical description of HIES is a
triad of: (a) recurrent staphylococcal skin abscesses without
typical features of inflammation called “cold abscesses”, (b)
recurrent pneumonia with pneumatocele formation, and (c)
highly elevated levels of serum IgE. More recently, the
genetic basis was unraveled showing genetic heterogeneity
with both autosomal dominant (AD) and autosomal
recessive (AR) forms of HIES. AD HIES is caused by
dominant negative variants in the STAT3-gene (OMIM
147060) [34, 48]. AR HIES has been shown to be caused
by mutations causing loss of tyrosine kinase 2 (TYK2)
(OMIM 611521) or dedicator Of cytokinesis 8 (DOCK8)
(OMIM 243700). Most reported cases of AR HIES were
due to DOCK8 loss explaining 16 out of 20 families that
were described [20], while TYK2 loss has been described
only twice worldwide [20, 47, 86].
AD HIES is characterized by typical dysmorphic
features such as facial asymmetry, prominent forehead,
deep-set eyes, broad nasal bridge, wide fleshy nasal tip,
high-arched palate, and mild prognathism that become
apparent in late puberty (Fig. 2b)[ 26]. Furthermore, patients
may manifest skeletal abnormalities including failure or delay
of shedding primary teeth, pathologic fractures, and scoliosis
[26]. Patients may present with early-onset atopic dermatitis-
like eczema, which is resistant to treatment. Immunologically,
AD HIES is characterized by high serum IgE levels,
eosinophilia, chronic mucocutaneous candidiasis, and severe
recurrent airway and ENT infections with Staphylococcus
aureus, Streptococcus pneumoniae,a n dHaemophilus influen-
Fig. 2 Dysmorphic features in other syndromic PID. (a) Wiskott–
Aldrich syndrome: note the dry skin with eczema; (b) hyper-IgE
syndrome: note the broad nasal bridge, wide fleshy nasal tip, and mild
prognathism; (c-1, c-2) Hypo-/anhidrotic ectodermal dysplasia with
immunodeficiency: note the high square forehead and ectodermal
dysplasia with dry skin, nail dysplasia, and conical wide spaced teeth;
(d-1, d-2) Cartilage–hair hypoplasia: note the disproportional short
stature associated with fine and sparse hair; (e-1, e-2) 22q11.2 deletion
syndrome: note the mild hypertelorism, downslanting of palpebral
fissures, hooded eyelids, hypoplasia of the alae nasi, prominent nose
with squared nasal root and narrow alar base, and small square low-set
ears
Eur J Pediatr (2011) 170:295–308 301zae, and occasionally, Aspergillus. Pneumatoceles develop in
approximately 75% of patients.
Features such as dysmorphisms and skeletal problems
are variably associated with AR HIES, while pneumatocele
formation was infrequently seen in patients with DOCK8-
or TYK2-mutations [20]. Furthermore, patients may suffer
from asthma, allergies, central nervous system symptoms,
and autoimmune phenomena. In addition to the immuno-
logical features that are found in AD HIES, patients with
AR HIES demonstrate unusual susceptibility to various
viruses resulting in recurrent serious molluscum contagio-
sum and herpes simplex infections, while patients with
TYK2-associated HIES also demonstrated increased sus-
ceptibility to mycobacteria [20, 47, 90].
Importantly, AD HIES and a significant subgroup of AR
HIES (DOCK8) have been associated with early-onset
squamous-cell carcinoma and lymphoma in some patients.
Although it is clear that immune-defects underlie the HIES
phenotype, no straightforward simple quantitative changes in
B and T cell numbers and immunoglobulin levels have been
described, besides high levels of IgE and eosinophilia to
distinguish HIES from other diseases. However, in early
childhood, normal IgE levels cannot definitely rule out HIES
as these may increase at a later age as well. In older patients,
IgE levels may become normal again [26].
HIES can be suspected from the typical clinical picture
and diagnosis can be confirmed by mutational screening of
STAT3, TYK2, or DOCK8. Clinical suspicion can be
increased by following the NIH scoring system, which
especially helps identifying patients with STAT3-associated
HIES [27, 87]. Interestingly, a recent study showed that 25
patients with a clinical diagnoses of HIES (including
patients with AD HIES and AR HIES), all had impaired
TH17 responses, suggesting that this test may be used as a
first confirmation of a clinical suspicion of HIES [1]. As
such, it is now incorporated into the NIH scoring system
[87]. Differential diagnosis with severe atopic dermatitis
can be difficult in the first years of life, even more because
high levels of serum IgE (up to ∼25.000 U/ml) may be
present. WAS, characterized by severe intractable eczema
of neonatal onset, can be differentiated by testing for
microthrombocytopenia.
Normal IgE levels cannot definitely rule out HIES.
One should include Hyper-IgE syndrome, but also 
parasitic infections and atopic dermatitis in the 
differential diagnosis of high IgE levels. 
Hypo-/anhidrotic ectodermal dysplasia
with immune-deficiency
Hypo-/anhidrotic ectodermal dysplasia with immune-
deficiency (HED-ID; OMIM 300291) is characterized by
diminished or absent sweat glands, thin and sparse hair,
conical incisors, nail dysplasia, hypodontia, and immuno-
deficiency (Fig. 2c-1 and 2c-2). Most cases of HED-ID are
caused by hypomorphic mutations in the NEMO-gene
[nuclear factor κB (NF–κB) essential modulator], which is
located on the X-chromosome [14]. As the disease follows
an X-linked recessive inheritance pattern, mostly males are
affected,althoughaffectedfemaleshavebeendescribed.More
severe mutations in NEMO result in incontinentia pigmenti,
an ectodermal dysplasia without immunodeficiency that
presents exclusively in females. Hypermorphic mutations in
IκBα causes an autosomal dominant type of HED-ID and
has been reported twice [11, 35]. HED-ID is one of the many
different ectodermal dysplasias encompassing more than 200
conditions involving a combination of disorders of hair,
nails, teeth, and sweat glands. Some children with HED-ID
manifest a more severe phenotype with osteopetrosis and
lymphedema (OL-EDA-ID; OMIM 300301).
From early childhood on, affected patients may suffer
from unusually severe, life-threatening, and recurrent
bacterial infections of the lower respiratory tract, skin, soft
tissues, bones, digestive tract, leading to bronchiectasis,
chronic lung disease, intractable diarrhea, and failure to
thrive. The commonly implicated pathogens are S. pneumo-
niae, S. aureus, Pseudomonas, H. influenzae, and myco-
bacteria, but pathogens such as P. jiroveci and Candida
(causing opportunistic infections) have been described as
well [7, 31]. Also, increased susceptibility to HSV may
predispose to HSVencephalitis [50]. Severity and spectrum
of features may vary strongly. More recently, cases of
HED-ID have been described with few ectodermal features
but increased susceptibility to infections [50, 58].
Immunologically, it can be difficult to suspect HED-ID
from routine immunological assessment as findings are
generally non-specific. T and B cell numbers are mostly
normal but can be increased (especially naïve CD4+
CD45RA+ T cells) [31, 35]. In addition, immunoglobulin
levels may vary. However, in a retrospective study, 24 out of
41 (59%) of HED-ID patients had hypogammaglobulinemia.
Some of the latter group also had increased IgM levels and
thus demonstrated a phenotype reminiscent of hyper-IgM
syndrome. Other possibly distinctive features were a specific
polysaccharide antibody deficiency (in 13 out of 16 patients),
a specific antibody response defect (in 18 out of 28 patients)
and an elevated IgA level (in 13 out 35 patients) [31]. More
specific in vitro tests evaluating NF–κB activation after
specific stimuli such as TNFα and anti-CD40 may prove
useful in the future.
302 Eur J Pediatr (2011) 170:295–308Diagnosis is primarily based on the combination of
clinical features, including infectious problems and ecto-
dermal dysplasia, and can be confirmed by molecular
genetic testing of NEMO or IκBα. As the clinical picture
may be highly variable from typical patients to patients
without ectodermal dysplasia with recurrent pneumococcal
infections, setting the right diagnosis can be very difficult.
Differential diagnosis includes several ectodermal dysplasias
(OMIM 612782and612783) [22], hyper-IgM syndrome, and
milder forms of SCID.
Cartilage–hair hypoplasia
Cartilage–hair hypoplasia (CHH; OMIM 250250), also
known as metaphyseal chrondodysplasia McKusick type,
is a rare autosomal recessive short-limb dwarfism syndrome
associated with fine and sparse hair, defective cellular
immunity, and predisposition to several cancers (e.g., non-
Hodgkin′s lymphoma and basal cell carcinoma; Fig. 2d-1
and 2d-2) [75]. The syndrome is caused by mutations in the
RMRP-gene [62]. Incidence is higher in genetic isolates
such as in Finland and in the old-order Amish communities
in the USA [63]. The radiologic features include metaphy-
seal dysplasia with shortened tubular bones, bowed femora
with rounded distal epiphyses, disproportionally long
fibula, and cone-shaped epiphyses of the hand. Severity is
variable, and radiographic changes are often inconspicuous
in the first few years, although often, growth failure and
sparse hair can be seen [36]. Other less frequent clinical
features include defective erythropoiesis, bone marrow
aplasia, and Hirschsprung disease [80, 85].
Defective immunity is a major feature in CHH. An
increased tendency to infections (mainly bacterial pneumo-
nias) is present in 40–50%, predominantly in the first
2 years of life [64]. Early studies described CHH patients
who suffered from fatal complications of varicella [39]. In
some, severe autoimmune features have been described
including autoimmune hemolytic anemia and autoimmune
enteropathy [5]. Morbidity and mortality are both directly
the consequence of immune dysfunction [41].
In CHH, usually, only cellular immunity is involved, but
sporadically, both cellular and humoral immunity show
defects. One third of the patients show lymphopenia, and
over 80% show abnormal lymphocyte proliferation upon
stimulation with mitogens. IgA and/or IgG subclass
deficiency is present in more than one third of CHH
patients [40].
In view of possible deficient immunity, it is recommended
that all affected CHH patients are carefully monitored for
signs of increased susceptibility to infections during the first
2 years of life. Several studies suggest that many individuals
with CHH can safely receive live vaccines, although these
should be avoided in CHH patients who clearly have SCID
[64].
As metaphyseal abnormalities on radiographs may 
be absent in infancy, Cartilage-Hair Hypoplasia 
should be considered in all patients with a small 
stature and unexplained lymphopenia.
22q11.2 deletion syndrome/Shprintzen syndrome/
DiGeorge syndrome
The 22q11.2 deletion syndrome (OMIM 192430), the most
common human deletion syndrome, is characterized by a
plethora of clinical features [65]. TBX1, one of the genes
located in the deleted region, is considered to be the major
gene involved. DiGeorge syndrome (historically referring
to patients with heart, thymus, and parathyroid gland
abnormalities) and Shprintzen syndrome/Velo-Cardio-Facial
syndrome (characterized by cleft palate or velopharyngeal
insufficiency, congenital heart malformations, and a typical
facial Gestalt) not only share clinical features but also a
commondeletion.Forthisreason,“22q11deletionsyndrome”
isthe preferred nomenclature todescribe these clinical entities
associated with this deletion. Conotruncal heart malforma-
tions (50–80%), such as tetralogy of Fallot or interruption of
the aortic arch form the most common group of congenital
malformations. The face is typically characterized by hooded
eyelids, a bulbous nasal tip with hypoplastic alae nasi and
smallears(Fig.1i, j)[ 65]. Psychomotor development is often
delayed, and an increased incidence of psychosis is reported
[25].
Recurrent ENT infections are the most common immuno-
logical feature. A fraction of 22q11 patients also develop
autoimmunediseasessuchasjuvenilerheumatoidarthritisand
hematologic autoimmune disease [12, 15]. Although infec-
tious problems are mild to moderate in the majority of
patients, an estimated 80% of 22q.11.2 deletion patients have
low Tcells. Remarkably, there is a slower decrease of T cells
compared with age-related control individuals [43]. In
addition to T cell abnormalities, IgA deficiency [71],
impaired responses to vaccines, and frank hypogammaglo-
bulinemia have been described. Subtle defects in the B cell
compartment such as decreased proportions of memory B
c e l l sh a v ea l s ob e e nr e p o r t e d[ 43]. Only 1% of patients lack
T cells due to aplasia of the thymus, which has classically
been described as DiGeorge syndrome. This specific subset
of patients is at risk for serious infections and requires
irradiated blood products to prevent graft versus host disease.
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of serum immunoglobulin levels is recommended.
The immune status should be checked in infants 
with 22q11.2 deletion syndrome before 
administering blood products, in order to determine
if irradiation of the blood is indicated.
Down syndrome
Down syndrome is the most common chromosomal
disorder and is commonly caused by trisomy 21. It is
generally thought that changes in expression levels of
multiple genes on chromosome 21 and secondary on other
chromosomes are causative of the phenotype (“the gene
dosage hypothesis”). Studies in patients with partial trisomy
have pointed at certain regions on chromosome 21 for
disorders such as leukemia and congenital heart disease, but
have not yet shown linkage to a particular region with
respect to increased susceptibility to infections [37]. More
likely, subtle differences in expression of multiple genes are
involved, affecting a variety of cell types thereby resulting
in immune imbalance [60, 72].
Infections of especially the lower respiratory tract
contribute significantly to morbidity and mortality in
patients with Down syndrome [89]. Also, upper respiratory
tract infections are more common than in children without
trisomy 21 [33]. Specifically, it was recently shown that
Down syndrome is an independent risk factor for severe
lower respiratory tract infections with respiratory syncytial
virus with an OR of 12,6 [4, 44]. To what extent an
underlying immunological defect is causative remains a
matter of discussion, as multiple other causes may influence
infection rate as well (e.g., more frequent institutionaliza-
tion, aspiration). Several differences in B, T, and NK cell
numbers have been reported in children with Down
syndrome as well as changes in immunoglobulin levels
and granulocyte function, which have not been consistent
and mostly cannot be interpreted simply as a cause of
immunodeficiency [8, 9, 38, 45, 61, 77]. As such, most
findings in routine immunological screening, at the mo-
ment, do not contribute to identifying those children at risk
for recurrent infections and do not provide a therapeutic
value. An interesting exception to this was the recent
observation that MBL deficiency increases susceptibility to
respiratory tract infections in Down syndrome patients,
which may be used to identify patients at risk for infectious
disease such as RSV [51].
Discussion
In this report, we provided an overview of some of the most
important syndromic immunodeficiencies. Key in identify-
ing syndromic immunodeficiencies is the awareness that
increased susceptibility to infections or immune dysregula-
tion in a patient known to have other pathology may hint at
an underlying genetic syndrome. Other organ systems
frequently found to be involved are the ectodermal,
skeletal, nervous, and gastrointestinal systems. Clinical
features not directly associated with the immune defect
may be prominent and be the first presentation. For this,
Table 1 is providing a differential diagnosis on the basis of
several key features. On the other hand, syndromic
immunodeficiencies may present with serious infections as
well, with extraimmune symptoms arising at a later time
point.
Clinical presentation and coming to a diagnosis Microce-
phaly with recurrent infections may point at one of the
several DNA repair or DNA maintenance disorders. Small
stature and intrauterine growth retardation may be impor-
tant clues to the correct diagnosis because disorders such as
Cernunnos deficiency, Bloom syndrome, and Hoyeraal
Hreidarsson syndrome frequently have proportional growth
retardation, which is already present at birth. Severe
difficulty to treat “eczema” and microthrombocytopenia in
a male makes the diagnosis of WAS almost certain. Patients
with chromosomal aberrations such as 22q11 deletion
syndrome most likely present with other features such as
facial dysmorphisms, cardiac defects, or velopharyngeal
insufficiency because the immune-defect is mostly mild.
Thorough examination of the mucocutaneous surface for
atopic dermatitis, ectodermal dysplasia, candidiasis, hypo-
pigmentation, or warts may be very helpful in delineating
the specific syndrome.
Opportunistic infections with cryptococcal or invasive
fungal infections, are rarely seen in most syndromic
immunodeficiencies but may be present in WAS, ICF
syndrome, Hoyeraal–Hreidarsson syndrome, HED-ID,
HIES, and Cartilage–hair hypoplasia. In A-T and NBS,
opportunistic infections have never been described. In
Chediak–Higashi syndrome and Griscelli syndrome
severe immune dysregulation such as hemophagocytic
Down syndrome patients may be at increased risk 
for recurrent infections, careful follow-up should 
identify those patients in need of supportive
measures.
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frequently.
An increased risk for malignancy has been reported in
multiple syndromic immunodeficiencies. In DNA repair
disorders like A-T, NBS, and Bloom syndrome there is a
high risk for malignancy, and patients are mostly at risk for
leukemias, lymphomas, and solid tumors later in life.
Treatment may be difficult, because conventional radiation
dosages are dangerous, radiomimetic drugs may have to be
avoided and other cytostatics have to be used at reduced
dosages. Therefore, patients need a specific therapeutic
approach. Also in WAS, CHH, and HIES, there is an
increased risk for malignancies (mainly lymphomas), which
warrants careful follow-up irrespective of the immunological
status and extending beyond pediatric age.
Early diagnosis is essential for adequate treatment and
follow-up Because of the complex pathology in many of
these syndromes, follow-up in a multidisciplinary team is
warranted. In general, immunological surveillance isthe same
as in other primary immunodeficiencies (see the first paper in
this educational series by de Vries et al.). Inactivated vaccines
canbeadministeredwithoutproblem,butcareshouldbetaken
with administering live-attenuated vaccines. Patients at risk
for opportunistic or other infections may be treated with
prophylactic antimicrobial agents. For more severe humoral
immunodeficiency, immunoglobulin substitution is indicated.
As some of the immunodeficiency syndromes have a poor
prognosis due to a severe course of the disease, conservative
treatment withsupportingmeasuresmay not besufficient.For
several diseases such as HED-ID, severe WAS, and CHH,
bone marrow transplantation has been employed with great
success [5, 10, 17, 57, 59].
Bone marrow transplantation has improved prospects for
many patients with a syndromic PID For WAS boys who
received BMT from a matched healthy sibling or closely
matched unrelated donor before the age of 5 years had a
greater than 85% probability of being cured [57]. In a recent
European collaborative survey, 16 patients with CHH and
immunodeficiency underwent HSCT, mostly at a young age
[5]. Overall survival was 62,5%, and surviving patients had
good reconstitution of the immune system with autoimmu-
nity resolved post-transplantation. Analogous to other patient
groups, the outcome with matched-related donors was
significantly better than haploidentical bone marrow trans-
plantation. In Cernunnos/XLF deficiency, Ligase IV defi-
ciency, Hoyeraal–Hreidarsson syndrome, ICF syndrome, and
NBS, successful bone marrow transplantation has been
reported, but long-term studies are not yet available [2, 18,
21, 28]. One of the remaining hopes is that BMT may also
decrease the risk for malignancy. As bone marrow trans-
plantation can have severe side effects, the decision to
transplant is strongly dependent on the type of disorder,
long-term prognosis, severity in which the patient is affected,
age of the patient, and availability of an adequate donor.
Genetic counseling is appropriate in all syndromic immu-
nodeficiencies Early diagnosis can be very important as
stringent follow-up may identify clinical problems at an
earlier stage and may make treatment easier. As many
syndromic immunodeficiencies may have an atypical presen-
tation, it is advisable to involve clinical geneticists at an early
stage. The clinical geneticist can also help in counseling the
parentsandhelpingthemadapttothesituation.Moreover,itis
appropriate to offer genetic counseling (including discussion
of potential risks to offspring and reproductive options) to
parents with a previous affected child or to young adults who
are affected or at risk of being carriers. Obviously, the optimal
timing for counseling on the recurrence risk, clarification of
carrier status, and discussion of the availability of prenatal
testing is before a new pregnancy is conceived.
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